GHS Cancer Institute — Greenville, South Carolina

GHS Cancer Institute is a clinical research site located in Greenville, South Carolina, United States 29605.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

GHS Cancer Institute has participated in 9 clinical trials.

Therapeutic areas: Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Unresectable Melanoma, Metastatic Melanoma.

Sponsors: Pfizer, Bristol-Myers Squibb, Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Greenville

Browse all research sites in South Carolina · View every site in Greenville

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GHS Cancer Institute?

GHS Cancer Institute has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GHS Cancer Institute conducted?

GHS Cancer Institute has 9 clinical trials on record. Their work covers Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Unresectable Melanoma, Metastatic Melanoma.

Is GHS Cancer Institute accredited by Crixeo Clinical Trials?

GHS Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GHS Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.